PL3250181T3 - Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw - Google Patents
Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestawInfo
- Publication number
- PL3250181T3 PL3250181T3 PL15798554T PL15798554T PL3250181T3 PL 3250181 T3 PL3250181 T3 PL 3250181T3 PL 15798554 T PL15798554 T PL 15798554T PL 15798554 T PL15798554 T PL 15798554T PL 3250181 T3 PL3250181 T3 PL 3250181T3
- Authority
- PL
- Poland
- Prior art keywords
- minoxidil
- kit
- pharmaceutical formulation
- topical use
- based pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20141770 | 2014-10-09 | ||
EP15798554.0A EP3250181B1 (en) | 2014-10-09 | 2015-10-08 | Minoxidil-based pharmaceutical formulation for the topical use and kit thereof |
PCT/IB2015/057694 WO2016055961A1 (en) | 2014-10-09 | 2015-10-08 | Minoxidil-based pharmaceutical formulation for the topical use and kit thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3250181T3 true PL3250181T3 (pl) | 2020-11-16 |
Family
ID=51904070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15798554T PL3250181T3 (pl) | 2014-10-09 | 2015-10-08 | Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3250181B1 (pl) |
ES (1) | ES2813433T3 (pl) |
PL (1) | PL3250181T3 (pl) |
WO (1) | WO2016055961A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107602875A (zh) * | 2017-10-16 | 2018-01-19 | 青岛海之林生物科技开发有限公司 | 一种速溶海藻酸钠的制备方法 |
KR20210027271A (ko) | 2018-05-30 | 2021-03-10 | 폴리카 인코포레이티드 | 모발 성장을 촉진하는 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139619A (en) | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4596812A (en) | 1976-05-24 | 1986-06-24 | The Upjohn Company | Methods and solutions for treating male pattern alopecia |
EP0177223B1 (en) | 1984-09-24 | 1990-02-28 | Michael Mezei | Pharmaceutical multi-phase composition |
US4828837A (en) | 1987-03-30 | 1989-05-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition, its production and application |
US5030442A (en) | 1987-03-30 | 1991-07-09 | Liposome Technology, Inc. | Non-crystalline minoxidil composition |
FR2717683B1 (fr) | 1994-03-22 | 1996-06-28 | Fabre Pierre Cosmetique | Composition capillaire à base de minoxidil. |
US5834014A (en) * | 1995-10-06 | 1998-11-10 | The Regents Of The University Of Michigan | Stimulation of hair follicles |
US20110112125A1 (en) | 2009-11-09 | 2011-05-12 | Tritech Biopharmaceuticals Co., Ltd. | Novel hair growth composition |
-
2015
- 2015-10-08 EP EP15798554.0A patent/EP3250181B1/en active Active
- 2015-10-08 ES ES15798554T patent/ES2813433T3/es active Active
- 2015-10-08 WO PCT/IB2015/057694 patent/WO2016055961A1/en active Application Filing
- 2015-10-08 PL PL15798554T patent/PL3250181T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
ES2813433T3 (es) | 2021-03-23 |
EP3250181B1 (en) | 2020-06-03 |
EP3250181A1 (en) | 2017-12-06 |
WO2016055961A1 (en) | 2016-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1249103B (zh) | 多環氨甲醯基吡啶酮化合物及其藥物用途 | |
HK1244000B (zh) | 多環氨基甲酰吡啶酮化合物及其藥物用途 | |
EP3302442A4 (en) | PHARMACEUTICAL FORM AND USE THEREOF | |
IL252477A0 (en) | 2-aminopyrimidine compound, pharmaceutical structure and its use | |
SG11201701292XA (en) | Topical formulation | |
IL268056A (en) | Recipes for external use containing cyclosporine and methods of using them | |
EP3434285A4 (en) | PHARMACEUTICAL COMPOSITION AND USES THEREOF | |
HK1231376A1 (zh) | 局部製劑及其應用 | |
PT3426294T (pt) | Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina | |
IL266537A (en) | pharmaceutical preparation | |
HK1245113A1 (zh) | 藥物組合物及其用途 | |
GB201502845D0 (en) | Topical pharmaceutical formulation | |
ZA201807851B (en) | Pharmaceutical formulation | |
PL3373976T3 (pl) | Preparaty do stosowania miejscowego i ich zastosowanie | |
PL3250181T3 (pl) | Formulacja farmaceutyczna na bazie minoksydylu do stosowania miejscowego i jej zestaw | |
GB201609968D0 (en) | Topical pharmaceutical formulation | |
GB201616767D0 (en) | New pharmaceutical use | |
AU2014901186A0 (en) | Therapeutic Agents and Uses Thereof |